Table 2.
Vital signs, clinical manifestations and biochemical data of the patients (n = 43)
Variables
|
Data
|
Vital signs | |
Heart rate (time/min), mean ± SD | 87.2 ± 3.1 |
Systolic pressure (mmHg), median (Q1, Q3) | 101.0 (94.5, 113.0) |
Diastolic pressure (mmHg), mean ± SD | 66.2 ± 1.7 |
Clinical manifestations | |
Fever (No/Yes) | 26/17 |
Abdominal pain (No/Yes) | 1/42 |
Diarrhea (No/Yes) | 14/29 |
Fecal occult blood (No/Yes) | 23/20 |
Mucus or bloody purulent stool (No/Yes) | 28/15 |
Lose weight (≥ 5 kg) (No/Yes) | 4/39 |
Abdominal mass (No/Yes) | 29/14 |
Toxic megacolon (No/Yes) | 41/2 |
Gastrointestinal hemorrhage (No/Yes) | 29/14 |
Intestinal obstruction (No/Yes) | 19/24 |
Intestinal perforation (No/Yes) | 34/9 |
Perianal disease (No/Yes) | 35/8 |
Extraintestinal manifestations (No/Yes) | 27/16 |
Oral ulcer (Yes) | 13 |
Pyoderma gangrenosum (Yes) | 1 |
Peripheral spondyloarthritis (Yes) | 6 |
Others (Yes) | 2 |
Biochemical data | |
White blood cell (× 109/L), mean ± SD | 6.7 ± 0.6 |
Neutrophil count (× 109/L), mean ± SD | 4.6 ± 0.5 |
Hemoglobin (g/L), mean ± SD | 103.6 ± 4.5 |
Platelets (× 109/L), mean ± SD | 343.2 ± 25.7 |
Alanine aminotransferase (U/L), median (Q1, Q3) | 11.0 (8.0, 14.0) |
Aspartate aminotransferase (U/L), median (Q1, Q3) | 14.0 (10.3, 18.8) |
Albumin (g/L), mean ± SD | 30.6 ± 1.5 |
Lactate dehydrogenase (U/L), median (Q1, Q3) | 127.0 (102.0, 140.0) |
Creatinine (μmol/L), mean ± SD | 60.7 ± 3.0 |
Potassium (mmol/L), mean ± SD | 3.8 ± 0.1 |
Prothrombin time (s), mean ± SD | 12.2 ± 0.2 |
Activated partial thromboplastin time (s), median (Q1, Q3) | 29.3 (26.5, 32.9) |
C-reactive protein (g/L), median (Q1, Q3) | 26.3 (16.3, 71.4) |